Tongji Hospital clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19
What changed in the last 30 days
8 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 7 with minor changes only.
- Minor: Remimazolam and Ciprofol TIVA on PRAE in Pediatric Tonsillectomy and Adenoidectomy Trial completed
-
Minor: 4 trials marked Unknown by the registry's verification sweep Changed
- Minor: Sintilimab Plus Lenvatinib as Adjuvant Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis (PVTT) After Surgical Resection Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2023); last known: Not Yet Recruiting
- Minor: HYPIC · Hydroxychloroquine · Inflammatory Cardiomyopathy Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
- Minor: Liposomal Bupivacaine and Bupivacaine for TTMPB in Median Sternotomy Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
- Minor: Artificial Intelligence Empowered Anesthesia Ultrasound Guided Regional Anesthesia Training Changed Registry marked status Unknown (sponsor has not verified the record since Aug 2024); last known: Not Yet Recruiting
- Notable: STEPS · Stereotactic Thrombolysis With Tenecteplase for Supratentorial Intracerebral Hemorrhage Primary endpoint(s) modified
- Minor: Fospropofol Disodium TIVA and IVIH on Surgical Field Quality in Adult ESS Primary completion pushed from Sep 30, 2026 to Dec 30, 2026
- Minor: Mindfulness Intervention on Minimally Invasive Vascular Surgery Start date pushed from Oct 2026 to Nov 2026
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-11-18 | NCT07944846 A Prospective, Multicenter, Observational Study to Evaluate the Efficacy and Safety of… | Recruiting | |
| 2026-11-18 | NCT07947043 Exploratory Clinical Study of Autologous Tumor-Infiltrating Lymphocytes (TIL) Injection | Phase 1 | Recruiting |
| 2026-11-16 | NCT07938658 Iparomlimab and Tuvonralimab Injection (QL1706)Combined With Chemotherapy (AG) and SBRT… | Phase 2 | Active, Not Recruiting |
| 2026-11-12 | NCT07934121 MIRV in Combination With Suvemcitug for Partially Platinum-Sensitive Ovarian Cancer | Phase 2 | Not Yet Recruiting |
| 2026-11-09 | NCT07927101 Effects of a Preoperative Capsaicin-Containing Diet on Postoperative Liver Injury Repair | Not Yet Recruiting | |
| 2026-11-04 | NCT07914985 Application of Peer Video Feedback Combined With Teacher Evaluation on Cardiopulmonary… | Completed | |
| 2026-10-23 | NCT07891338 Exploratory Study of the Efficacy of HAL-PDT in CIN 3 | Phase 2 | Not Yet Recruiting |
| 2026-10-21 | NCT07885566 RWS of PDT for CIN 2 | Not Yet Recruiting |
Active trials by phase
| Early Phase 1 | 11 | |
| Phase 1 | 8 | |
| Phase 1/2 | 5 | |
| Phase 2 | 26 | |
| Phase 2/3 | 2 | |
| Phase 3 | 6 | |
| Phase 4 | 11 |
Not charted: 113 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials, top 10 of 42
Liver Cancer (28) · Ovarian Cancer (11) · Cervical Cancer (8) · Multiple Sclerosis (7) · Cholangiocarcinoma (6) · Heart Disease (6) · Lung Cancer (6) · Lupus (SLE) (6) · Myasthenia Gravis (5) · Stroke (5)
Get alerts when Tongji Hospital's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.